Breast
cancer is not just an issue for women on a global scale; however, one man is
working to help lower breast cancer mortality rates. His solution: the
iBreastExam.
The Economic Times |
Women are
affected by breast cancer each year, both in and outside of the United States.
Amazon |
This was
true for a poet that was diagnosed with breast cancer, Audre Lorde. As she
described her experience in her book The Cancer Journals she battled
breast cancer and a mastectomy. Throughout the book, she talks about just her
personal experience with cancer, however, in the beginning of the book, she
discusses how many different women go through the challenges of breast cancer.
Lorde states, “Breast cancer and mastectomy are not unique experiences, but
ones shared by thousands of american women” (Lorde, 8).
However,
it is not just women who are diagnosed that are affected, but it is also their
friends and families that are dealing with this tough time as well.
Mihir Shah, a computer engineer also had
his own experience with breast cancer that lead to something greater. Shah was
getting married right after his mother-in-law was diagnosed with breast cancer.
After this experience with breast cancer, Shah realized how lucky he was that
the women in his life, both in the United States and India were fortunate to
have the accessibility to receive proper breast cancer screenings.
According
to an article that was published by “The Lancet”, the five year United States
survival rate for breast cancer is significantly different than a lot income
country. For example, the five year survival rate for breast cancer in the
United States is 90.2 percent and the five year survival rate for breast cancer
in India is 66.1 percent. There are many reasons for this, such as lack of
access to adequate healthcare, healthcare is unaffordable, or lack of testing
resources.
CPN Public Information |
But why
is women’s health not a priority and why are there no options for alternative
types of testing?
This is
exactly what Shah was thinking when he tried to develop a way to bring cancer
testing to low income countries, like India. This lead Shah to help develop a
new type of breast cancer testing that was pain free, quick, and easy to learn.
This is when the iBreastExam was developed. This device can offer women a quick and
affordable test to see if they may have breast cancer or not.
This new
device is made out of ceramic and puts off no radiation to the woman’s (or
man’s) body. This new technology is easy to use, a quick assessment, and is not
invasive. This device completely changes the the way that cancer screening is
conducted.
According
to a New York Times article, the same one where Shah was
introduce, explained how the device itself works. The article states that the
device, which is small and portable, connects to a smartphone. The trained
professional then goes over four quadrants of the patient’s breast, which will
either appear green on the screen, meaning the area is clear, or red, where the
area is questionable and the patient is going to have to a nearby hospital to
talk with a doctor about the possible cancerous area. This type of screening
takes only 10 minutes and the person that is conducting the screening can be
trained in just 8 hours. The results of the test automatically save to the
smartphone and the patient gets the results right away.
Another
major added benefit to this type of screening is that there is no radiation
being given to the patient. This is one of the main concerns with mammograms,
is that women are concerned about the radiation that is being exposed. Also,
mammograms just flat out hurt, causing women to steer clear of them.
Dallas Post Tribune |
I would
say that it most definitely has changed women’s health and cancer awareness for
the better. This is especially true in low income countries where there is a
lot of less advocacy or education provided for breast cancer. With the device
such as the iBreastExam, which has been implemented in twelve countries and 200
plus locations worldwide, more and more women are getting testing and treated
for breast cancer. The iBreastExam also gets more and more women in the clinics
to receive education surrounding breast cancer, such as signs and symptoms of
breast cancer and how to conduct at home breast exams.
However,
the only issue with the iBreastExam being widespread around the world is the different cultural
practices within each country.
In the New York Times article, the author discusses how
officials were worried about the iBreastExam being a device that uses
ultrasound. The developers of the device had to show that there was no
ultrasound technology within the device. This worry from the officials is
because the ultrasound technology can determine the sex of a fetus. However,
the ultrasound technology is now banned from India due to the fact that mothers
were terminating the pregnancy due to the sex of the fetus, causing a very
skewed population. So, different approaches and methods of convincing that the
device is safe and effective in each country may be difficult but it is
ultimately necessary.
Overall,
the iBreastExam is a major step in the right direction in terms of advocacy
for turning around the statistics of breast cancer cases around the world.
Although it may not the absolute best type of cancer detection, it is better
than nothing, which is what women had before.
Regardless
of the device, women around the world need to know about the cancers that can
take over their body. Cost and location of these services should not impact the
chances of these women potentially saving their own lives.
Related Course Reading: Lorde, Audre.
"The Cancer Journals: Special edition." San Francisco: Aunt
Lute (1997).
No comments:
Post a Comment